15108 Long-term efficacy and safety of dupilumab in adolescents with atopic dermatitis: Results from an open-label extension trial (LIBERTY AD PED-OLE)

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2020
This article has no abstract
Epistemonikos ID: 12e3deb241bf4cc3868dc9e5ff54b0cdc34082b5
First added on: Feb 12, 2025